A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy

NCT00236730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Epilepsies, Partial
Seizures

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.